# Feature Assessment Study for Indications Based Programming

> **NCT00711893** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 301 (actual)

## Conditions studied

- Ventricular Tachycardia
- Ventricular Flutter
- Ventricular Fibrillation
- Heart Failure

## Interventions

- **DEVICE:** Cognis 100-D, Teligen DR and VR 100 HE

## Key facts

- **NCT ID:** NCT00711893
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711893, "Feature Assessment Study for Indications Based Programming". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00711893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*